Masimo Corporation $MASI Shares Purchased by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP increased its position in shares of Masimo Corporation (NASDAQ:MASI) by 7.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,522,049 shares of the medical equipment provider’s stock after purchasing an additional 102,799 shares during the quarter. Masimo accounts for approximately 0.8% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 22nd largest holding. Westfield Capital Management Co. LP owned 2.83% of Masimo worth $197,958,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC acquired a new stake in shares of Masimo during the fourth quarter worth about $27,000. Rothschild Investment LLC lifted its holdings in shares of Masimo by 12,950.0% during the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 259 shares during the period. Torren Management LLC acquired a new stake in shares of Masimo during the fourth quarter worth about $35,000. Smartleaf Asset Management LLC lifted its holdings in shares of Masimo by 80.0% during the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 136 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in shares of Masimo during the third quarter worth about $46,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on MASI shares. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Stifel Nicolaus set a $180.00 price target on Masimo in a report on Tuesday, February 17th. Finally, Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Nine analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $180.40.

Masimo Trading Up 0.1%

Shares of NASDAQ:MASI opened at $178.90 on Friday. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $179.00. The company has a market capitalization of $9.37 billion, a PE ratio of -16.97, a PEG ratio of 1.81 and a beta of 1.11. The business has a 50 day moving average of $178.43 and a two-hundred day moving average of $159.18. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.